- Home
- HUMA vs ARAY Comparison
HUMA vs ARAY Comparison
Compare HUMA & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- ARAY
- Stock Information
- Founded
- HUMA 2004
- ARAY 1990
- Country
- HUMA United States
- ARAY United States
- Employees
- HUMA N/A
- ARAY N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- ARAY Medical/Dental Instruments
- Sector
- HUMA Health Care
- ARAY Health Care
- Exchange
- HUMA Nasdaq
- ARAY Nasdaq
- Market Cap
- HUMA 221.8M
- ARAY 229.3M
- IPO Year
- HUMA N/A
- ARAY 2007
- Fundamental
- Price
- HUMA $1.19
- ARAY $1.51
- Analyst Decision
- HUMA Strong Buy
- ARAY
- Analyst Count
- HUMA 6
- ARAY 0
- Target Price
- HUMA $14.60
- ARAY N/A
- AVG Volume (30 Days)
- HUMA 2.8M
- ARAY 686.4K
- Earning Date
- HUMA 05-13-2025
- ARAY 04-30-2025
- Dividend Yield
- HUMA N/A
- ARAY N/A
- EPS Growth
- HUMA N/A
- ARAY N/A
- EPS
- HUMA N/A
- ARAY 0.01
- Revenue
- HUMA N/A
- ARAY $465,251,000.00
- Revenue This Year
- HUMA N/A
- ARAY $6.97
- Revenue Next Year
- HUMA $1,178.20
- ARAY $5.02
- P/E Ratio
- HUMA N/A
- ARAY $223.59
- Revenue Growth
- HUMA N/A
- ARAY 8.06
- 52 Week Low
- HUMA $1.15
- ARAY $1.40
- 52 Week High
- HUMA $9.97
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- HUMA 29.75
- ARAY 48.25
- Support Level
- HUMA $1.35
- ARAY $1.34
- Resistance Level
- HUMA $1.26
- ARAY $1.65
- Average True Range (ATR)
- HUMA 0.09
- ARAY 0.08
- MACD
- HUMA 0.03
- ARAY 0.01
- Stochastic Oscillator
- HUMA 2.78
- ARAY 62.16
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.